Following its successful pilot program at JFK International Airport, XpressSpa (NASDAQ:XSPA) +5.8% PM signed a contract with the Port Authority of New York and New Jersey to provide diagnostic COVID-19 testing at Newark Liberty International Airport through its XpresCheck brand; expected to be fully operational in the week of August 17.
It is currently building a modular constructed testing facility within Terminal B, hosting 6 separate testing rooms with a capacity to administer over 350 tests/day.
Commencing Aug 10, XpressSpa will expand its testing services to the traveling public as airport traffic likely to increase in upcoming months.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.